IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CHI Advisors LLC

Q1 2020 Holdings

Filed 2020-05-14 | 13 holdings | $809.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Corvus Pharmaceuticals Inc(CRVS)COM221015100$768.0K364,13294.9%
Orchard Therapeutics PLCADS68570P101$22.3K2,962,2672.8%
Precision Biosciences IncCOM74019P108$5.7K940,5600.7%
Livongo Health Inc(LVGO)COM539183103$2.6K90,0000.3%
Ovid Therapeutics Inc(OVID)COM690469101$2.5K828,4130.3%
Blueprint Medicines Corp(2L9)COM09627Y109$2.1K36,0000.3%
Kezar Life Sciences IncCOM49372L100$2.0K458,8870.2%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$1.7K39,3620.2%
Global Blood Therapeutics inCOM37890U108$80515,7500.1%
Myokardia IncCOM62857M105$70315,0000.1%
Adverum Biotechnologies Inc(ADVMCHF)COM00773U108$62363,7500.1%
Unum Therapeutics IncCOM903214104$389940,8050.0%
Bluebird BIO IncCOM09609G100$2766,0000.0%